Clinical Trial

Oral Biopsy Bleeding in Patients on Direct Oral Anticoagulants (DOACs)

Study acronym: DOACS_BX
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 9, 2026 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
Direct oral anticoagulants (DOACs) are increasingly used, but evidence on bleeding risk during oral soft tissue biopsy is limited. This prospective case-control study compared intraoperative, perioperative, and postoperative bleeding in 50 patients on uninterrupted DOAC therapy versus 50 anticoagulant-naive controls undergoing standardized oral soft tissue biopsy with suturing. All bleeding events were managed with local haemostatic measures. The study aims to determine whether DOAC continuation is safe for this procedure.
Trial Details
NCT Number NCT07520890
Lead Sponsor University of Pisa
Conditions Direct Oral Anticoagulants (DOACs), Oral Surgical Procedures
Enrollment 100 participants
Start Date 2026-04-01
Primary Completion 2026-05-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-09